CCRS Logo

Oncology 2026

INTERNATIONAL CONFERENCE ON MULTIDISCIPLINARY MANAGEMENT OF COMMON CANCERS

Pre-conference workshop on Genomics in Oncology - March 12, 2026

2026 March 13, 14 & 15 | IMA House, Kochi, Kerala

Dear Colleague,

Greetings from Kochi...!

We are extremely happy to invite you all to the beautiful city of Kochi for your esteemed participation in "ONCOLOGY 2026" - the international conference on multidisciplinary management of common cancers which is going to be held at the fabulous convention centre of IMA House, Kochi on 13th, 14th & 15th of March 2026.

Pre-Conference Workshop

There will be a pre-conference scientific programme on Genomics in Oncology on 12th March 2026. All of us should make use of this opportunity to update our knowledge in "PRECISION ONCOLOGY".

The conference will highlight clinical problems in daily practice of oncology through case-based panel discussions, lectures etc. There will be parallel sessions on Radiology for Oncologists, Target Volume Delineation in Oncology, how to be successful in abroad and opportunities abroad, E-contouring and applications of high-tech Radiation Oncology applied to SBRT in the management of metastatic disease, lung cancer etc. Practical tips for FRCR aspirants will be organised by faculty from UK and India Oncology residents may make use of "MEET “THE PROFESSOR" sessions.

There will be opportunities for paper presentation, poster presentation and also quiz programmes, all meant for different specialities of oncology. As in the previous years, the winners will be awarded gold, silver and bronze medals and two post graduate students will be awarded funding for further training in oncology.

You all are requested to kindly give wide publicity for this conference amongst your colleagues, students and friends to make it a grand success.

Soliciting your participation, guidance and support.

Thanking you
Yours Sincerely,

Prof. Dr. C.S. Madhu MD, DNB
Chairman

signature image

Dr. Manoj S MD, DM
Organising Secretary

signature image

Dr. Gayathri J Prakash MD, DNB
Joint Organizing Secretary

Mr. Anilkumar K. M.Sc, DRP
Treasurer

Mr. Abey Thomas
Joint Organizing Secretary

Oncology 2026 Conference Details

Conference Focus

International Conference on Multidisciplinary Management of Common Cancers

Emphasis on "PRECISION ONCOLOGY" with cutting-edge approaches to cancer care.

Key Dates

  • Pre-Conference Workshop: March 12, 2026 - Genomics in Oncology
  • Main Conference: March 13-15, 2026
  • Venue: IMA House Convention Centre, Kochi

Organized By

Cancer Control & Research Society

Email: oncology2026@gmail.com

Website: www.oncology2026.com

Program Schedule

Pre-Conference Workshop - March 12, 2026

Genomics in Oncology

Comprehensive workshop focusing on precision oncology and genomic applications in cancer care.

Main Conference Days

Day Date Focus Areas
Day 1 March 13, 2026 Opening ceremony, keynote lectures, AI in cancer care, precision medicine
Day 2 March 14, 2026 Multidisciplinary sessions, parallel workshops, "Meet the Professor" sessions
Day 3 March 15, 2026 Panel discussions, quiz competitions, award ceremony, closing

Parallel Sessions Include:

  • Meet the professor sessions for medical oncology residents
  • Radiology for Oncologists
  • CAR-T Cell Therapy
  • Immunotherapy and toxicity management
  • Target Volume Delineation in Oncology
  • E-contouring and High-tech Radiation Oncology
  • SBRT in Metastatic Disease Management
  • Opportunities and Success Strategies Abroad
  • FRCR Preparation Tips

Distinguished Faculty

Prof. Suresh Senan

Prof. Suresh Senan
PHD, FRCR, MRCP, Amsterdam

Professor of Clinical Experimental Radiotherapy
Amsterdam UMC, Netherlands

Dr. Najeeb Mohideen

Dr. Najeeb Mohideen
MD, FRCR, FASTRO, USA

Radiation Oncologist, Chairman - Radiosurgery Society
Illinois, USA

Dr. Kurian Joseph

Dr. Kurian Joseph
FRCR, FFRCSI, FRCP, Canada

Radiation Oncologist & Associate Professor
University of Alberta, Canada

Prof. M. V. Pillai

Prof. M. V. Pillai
MD, FACP, USA

Clinical Professor of Oncology
Thomas Jefferson University, USA

Dr. Ajithkumar

Dr. Thankamma V. Ajithkumar
MD, FRCR, UK

Consultant Clinical Oncologist
Cambridge University Hospitals, UK

Dr. Ajith Venniyur

Dr. Ajith Venniyur
MD, MRCP, Oman

Medical Oncologist
Royal Hospital, Muscat

Dr. Ashok Komaranchath

Dr. Ashok Komaranchath
MD, DM, MRCP, FRCP, Oman

Medical Oncologist
Burjeel Cancer Institute, Oman

Prof. Rojymon Jacob

Prof. Rojymon Jacob
MD, FRCR

Medical Oncologist
University of Mississippi Medical Center

Prof. Saby George

Prof. Saby George
MD, FACP, New York

Professor of Medicine & Oncology
Roswell Park, USA

Prof. Ben George

Prof. Ben George
MD, FACP, USA

Professor of Medicine & Oncology
Mayo Clinic , Minnesota , USA

Prof. John Walker

Prof. John Walker
MD, FACP, Canada

Medical Oncologist
Cross Cancer Institute, Canada
University of Alberta, Canada

Dr. Ajith Gopinadhan Nair

Dr. Ajith Gopinadhan Nair
MD, FRCR, UK

University Hospitals of Derby and Burton NHS Foundation Trust

Venue & Location

IMA House Convention Centre

Location: Kochi, Kerala, India

About: Fabulous convention centre with world-class facilities for international conferences.

About Kochi

Kochi, often called the "Queen of Arabian Sea," is a beautiful port city in Kerala, India. Known for its:

  • Rich cultural heritage and historical significance
  • Modern infrastructure and connectivity
  • Excellent hospitality and accommodation facilities
  • Easy accessibility via air, rail, and road networks
  • Pleasant weather during March

Getting There

Transportation Details
Airport Cochin International Airport (COK) - Well connected internationally
Railway Ernakulam Junction - Major railway hub
Road Excellent highway connectivity to all major cities

Accommodation

Good accommodation is available at venue. However, accommodation in 5star/4star/3star/ordinary are available and our travel agent Ms. Moon Days may be contacted.

Moon Days

Email: namaste@moondays.in

Contact: Paul Vinu - +91 8086 530 177

Registration Information

Early Registration

Register early to secure your spot and avail special discounts!

Registration Fees

Category Early Bird (Till 01-02-2026) Regular (Till 01-03-2026) On Spot
Students/Residents ₹2,500 ₹3,000 ₹3,500
Faculty/Consultants ₹5,000 ₹6,000 ₹7,000
International Delegates $150 $200 $250
Industry/Corporate ₹8,000 ₹10,000 ₹12,000

Note
1. Conference registration is mandatory to attend the pre-conference scientific session.
2. The post graduate students attending preconference will get Rs.1000/- at 6PM/end of session on that day.

Registration Includes

  • Access to all scientific sessions
  • Pre-conference workshop (Genomics in Oncology)
  • Conference materials and proceedings
  • Welcome refreshments and lunch
  • Networking opportunities
  • Certificate of participation
  • CME credits

Awards & Recognition

  • Best paper presentation awards (Gold, Silver, Bronze medals)
  • Best poster presentation awards
  • Quiz competition prizes
  • Two postgraduate student funding awards for further oncology training

How to Register

Email: oncology2026@gmail.com

Website: www.oncology2026.com

Contact: +91 9447 073 203 (Mr. Abey Thomas)

Organizing Committee

Leadership Team

Position Name Qualification
Chairman Prof. Dr. C.S. Madhu MD, DNB
Organizing Secretary Dr. Manoj S. MD, DM
Joint Organizing Secretary Dr. Gayathri J Prakash MD, DNB
Treasurer Mr. Anilkumar K. M.Sc, DRP
Joint Organizing Secretary Mr. Abey Thomas MBA

Organized By

Cancer Control & Research Society

Dedicated to advancing cancer research, education, and patient care through international collaboration and knowledge sharing.

Scientific Committee

The scientific committee comprises renowned oncologists, radiation oncologists, medical oncologists, and surgical oncologists from leading institutions across India and internationally. The committee is responsible for:

  • Curating the scientific program
  • Reviewing abstract submissions
  • Coordinating faculty presentations
  • Ensuring high academic standards
  • Facilitating knowledge exchange

Contact Information

Primary Contact

Mr. Abey Thomas - Joint Organizing Secretary

+91 9447 073 203

oncology2026@gmail.com

www.oncology2026.com

Online Presence

Platform Details
Official Website www.oncology2026.com
Email oncology2026@gmail.com
Registration Inquiries Same as primary email
Abstract Submission Details available on website

Venue Address

IMA House Convention Centre
Kochi, Kerala, India

For Inquiries About

  • Registration: oncology2026@gmail.com
  • Abstract Submission: Visit website for guidelines
  • Accommodation: Contact organizing committee
  • Sponsorship: Email for partnership opportunities
  • Travel & Visa: General travel information available

Stay Updated

For latest updates, program changes, and announcements, regularly visit our website or follow our communications.

We look forward to your participation in making Oncology 2026 a grand success!

Scientific Agenda

Explore the comprehensive scientific program featuring cutting-edge topics in oncology, multidisciplinary discussions, and innovative treatment approaches.

Featured Topics - Oncology 2026

Clinical Trials & Landmark Studies

  • VENUS Trial: Can we avoid SLNB in carefully selected node-negative breast cancer patients?
  • DESTINY Breast 09 (DB09) Trial: Trastuzumab deruxtecan (T-DXd) ± pertuzumab as first-line Rx for HER2-positive MBC
  • Recent Practice Changing Landmark Papers
  • ctDNA Guiding Treatment of Colorectal Cancer: Ready for Primetime?

Precision Medicine & Genomics

  • Debate: Genomic profiling in today's oncology practice – Should be done in all patients at diagnosis?
  • Genomics 101 for Oncologists
  • Molecular Case-Based Panel Discussion: Lung, Thyroid & Brain
  • Liquid Biopsy and ctDNA for Biomarker-Driven Therapies for Cancer Detection and Treatment
  • Genomic Insights in Perioperative Decision-Making in Non-Small Cell Lung Cancer: Navigating EGFR, ALK, and Emerging Biomarkers
  • Biomarker-Driven Adaptive Therapy: New Horizons in Head and Neck Cancer
  • ASCO/ESMO Joint Session: Biomarker-Driven Therapeutics: Translating Innovation Into Practice

Artificial Intelligence & Technology

  • Artificial Intelligence in Cancer Care: The Evolving Role of Decision Support in Care Delivery and Practical Application in Your Practice
  • AI-Based Image Biomarkers in Oncology, Radiology and Pathology
  • State of the Art in Utilizing Artificial Intelligence in Neuro-Oncology
  • The Future of Cancer Detection Is Coming

Breast Cancer

  • After a CDK4/6 Inhibitor: State of the Art in Hormone Receptor-Positive Metastatic Breast Cancer
  • Multidisciplinary Management of Brain Metastasis in Breast Cancer
  • What to De-escalate and for Which Breast Patients? De-escalation in Breast Surgery, Radiation and Systemic Treatment
  • Keynote Lecture: Breast Reconstruction - Choosing the Right Locoregional Flap
  • Lympho-Venous Anastomosis & Lymph Node Transfer in Breast Cancer: Indications & Techniques

HER2-Positive Tumors

  • Newer Paradigms in the Management of HER2+ Solid Tumors
  • Panel Discussion: Management of HER2+ Solid Tumors in the Current Era (HER2+ Gastric Cancer, Endometrial Cancer, and Biliary Tract Cancer)
  • Spotlight on Strategic Sequencing in HER2+ Metastatic Breast Cancer - Pfizer

Thoracic Malignancies

  • Tough Choices: Front-Line Treatment Dilemmas in EGFR Metastatic Non-Small Cell Lung Cancer
  • Lung Cancer - Non-Small Cell Metastatic
  • An Innovative Perspective on Advanced NSCLC Treatment
  • Sponsored Session: Tislelizumab in Lung Cancer: Current Evidence and Future Directions

Head, Neck & CNS Tumors

  • Panel Discussion: Locally Advanced HNSCC (1. Recurrent Head & Neck Cancer, 2. Locally Advanced Oral Cancer)
  • State-of-the-Art Technologies to Advance Outcomes for Patients with Head and Neck Squamous Cell Carcinoma
  • Novel Treatment Paradigms in Nasopharyngeal Carcinoma
  • Incorporating Targeted Therapy Into Neuro-Oncology Practice
  • Refining Local Therapies in Central Nervous System Oncology: Hitting the Bullseye
  • Therapeutics Options for Patients with Leptomeningeal Disease
  • Multidisciplinary Treatment of Anaplastic Thyroid Cancer

Gastrointestinal Cancers

  • Locally Advanced Rectal Cancer: Lessons Learned and Treatment Options on the Horizon
  • Adjunctive Therapies in Colon Cancer: As Good as a Drug?
  • Charting the Future of Gastroesophageal Cancer: Advancements in Biomarker Selection, Breakthrough Therapies and Overcoming Therapeutic Resistance
    • Biomarker and Mechanisms of Resistance to Immune Checkpoint Inhibitors
    • Toward Novel Immunomodulatory Strategies
    • Next Generation Therapeutics: ADCs, CAR T-Cells, BiTE
    • How to Move Forward from Early Stage
  • Esophageal Cancer: Current Standards in an Ever-Changing Treatment Landscape
  • Treatment Innovations in Pancreatic Cancer: Balancing Hope and Expectations
  • State of the Art in Care of Hepatobiliary Malignancies

Genitourinary Cancers

  • State of the Science: Advancing Frontiers—Novel Diagnostics and Therapeutics in Renal Cell Carcinoma and Urothelial Carcinoma
  • Genitourinary Cancer—Kidney and Bladder
  • Kidney Cancer: Treatment Free Interval After Immune Checkpoint Inhibitors
  • Prostate Cancer: Triplets and Doubles for Metastatic CSPC
  • Applying Real World Evidence in Advanced Prostate Cancer
  • State of the Art: Personalizing Treatment for Patients with mCRPC in 2025
  • New Frontiers in Prostate-Specific Membrane Antigen Radioligand Therapy
  • Bladder Cancer: Recent Advances in Systemic Therapy in the Perioperative and Metastatic Space
  • Updates in the Management of Penile and Germ Cell Tumors
  • Refining Treatment for Patients with Metastatic Germ-Cell Tumors

Gynecologic Cancers

  • Frontline Management of Ovarian Cancer
    • Is Primary Cytoreduction Still the Best Option?
    • Facing the Challenge of HRD Negative Ovarian Cancer
  • Advances in Systemic Management of Locally Advanced Cervical Cancer - Interlace to Keynote!
  • Molecular Classification of Endometrial Cancer and Treatment Implications in Current Era!
  • Systemic Therapy in Advanced Metastatic Endometrial Cancer in the Era of Molecular Signatures!
  • Endometrial Cancer: A New Staging System
  • Is Less More? Maximizing Outcomes by Tailoring Treatments to Patients: Oncofertility and Oncomenopause

Immunotherapy & Targeted Therapy

  • Connecting the Dots: Strategies for Academic and Community Synergy in Immunotherapy Toxicity Care
  • Toxicities of Immunotherapy Including CAR T-Cell Therapy
  • Systemic Anti-Tumor Immunity in Clinical Outcomes
  • Advancements and Challenges to Bringing Cell Therapy to Solid Tumors
  • Panel Discussion: Recently Launched ICIs (Serplulimab, Toripalimab, Tislelizumab etc) - Can They Replace Existing Already Approved Molecules?
  • Sponsored Session: Next-Gen Immunotherapy: Toripalimab Impact in the Management of Different Cancers
  • ADCs in Oncology: The Newer Drugs on the Horizon
  • Developmental Therapeutics: Molecularly Targeted Agents and Tumor Biology

Hematologic Malignancies

  • What's Next for Patients with 2L+ Relapsed or Refractory Multiple Myeloma?
  • Current and Future Directions in Immunotherapies in Myeloma
  • Sponsored Session: Treatment Options in 1st Line Management of CML
  • Sponsored Session: Advances in the Management of Advanced Hodgkin's Lymphoma

Sarcomas

  • Ultra-Rare Sarcomas: How Do We Move Forward?
  • Neo-adjuvant Therapy for Soft Tissue Sarcoma: New Developments and Ongoing Unanswered Questions

Special Populations & Supportive Care

  • Comprehensive Geriatric Assessment
  • "What About Cannabis?": Incorporating Evidence to Facilitate Informed Discussions with Patients and Caregivers
  • The Microbiome's Influence on Cancer Therapy: Insights and Innovations

Healthcare Policy & Technology Assessment

  • The Future of Health Technology Assessment (HTA) at the European Level

Note

This comprehensive list covers all 74 scientific topics that will be featured during Oncology 2026. The detailed schedule with timings, speaker assignments, and venue allocations will be available closer to the conference date.

Sessions include: Keynote lectures, panel discussions, debates, case-based discussions, molecular discussions, and sponsored sessions.

Stay tuned for the final program schedule!